Chemoinformaics analysis of 5,3-Dihexanoyl 3,6,7,4- tetramethoxyflavone
| Molecular Weight | 390.344 | nRot | 5 |
| Heavy Atom Molecular Weight | 372.2 | nRig | 18 |
| Exact Molecular Weight | 390.095 | nRing | 3 |
| Solubility: LogS | -3.777 | nHRing | 1 |
| Solubility: LogP | 2.606 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 50.9503 |
| nHD | 3 | BPOL | 27.6057 |
| QED | 0.602 |
| Synth | 2.71 |
| Natural Product Likeliness | 1.398 |
| NR-PPAR-gamma | 0.932 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.002 |
| HIA | 0.053 |
| CACO-2 | -5.007 |
| MDCK | 0.0000187 |
| BBB | 0.003 |
| PPB | 0.86043 |
| VDSS | 0.835 |
| FU | 0.262182 |
| CYP1A2-inh | 0.586 |
| CYP1A2-sub | 0.978 |
| CYP2c19-inh | 0.065 |
| CYP2c19-sub | 0.131 |
| CYP2c9-inh | 0.571 |
| CYP2c9-sub | 0.75 |
| CYP2d6-inh | 0.077 |
| CYP2d6-sub | 0.325 |
| CYP3a4-inh | 0.44 |
| CYP3a4-sub | 0.273 |
| CL | 3.544 |
| T12 | 0.85 |
| hERG | 0.18 |
| Ames | 0.28 |
| ROA | 0.249 |
| SkinSen | 0.649 |
| Carcinogencity | 0.018 |
| EI | 0.872 |
| Respiratory | 0.213 |
| NR-Aromatase | 0.869 |
| Antiviral | Yes |
| Prediction | 0.907026 |